| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Anwar A et al. | Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. | 2018 | Parasitol. Res. | pmid:29218442 |
| Yao JY et al. | Evaluation of nystatin isolated from Streptomyces griseus SDX-4 against the ciliate, Ichthyophthirius multifiliis. | 2015 | Parasitol. Res. | pmid:25645004 |
| Marcotty T et al. | In vitro titration of Theileria parva tick derived stabilates. | 2004 | Parasitology | pmid:15030000 |
| Jolivot PA et al. | [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. | 2012 | Pathol. Biol. | pmid:22361161 |
| Hachiya KA et al. | Candida esophagitis following antibiotic usage. | 1982 May-Jun | Pediatr Infect Dis | pmid:7145730 |
| Leibovitz E | Strategies for the prevention of neonatal candidiasis. | 2012 | Pediatr Neonatol | pmid:22503254 |
| Spencer R et al. | Antimicrobial therapy for surgical diseases of the gastrointestinal tract. | 1968 | Pediatr. Clin. North Am. | pmid:5638370 |
| Hildick-Smith G | Antifungal antibiotics. | 1968 | Pediatr. Clin. North Am. | pmid:4866900 |
| Cohen-Abbo A | Newborn with vesicular rash. Tinea corporis (tinea faciei). | 2000 | Pediatr. Infect. Dis. J. | pmid:10917228 |
| Goins RA et al. | Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. | 2002 | Pediatr. Infect. Dis. J. | pmid:12506950 |
| Hoppe JE | Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. | 1997 | Pediatr. Infect. Dis. J. | pmid:9076817 |
| JAHN CL and CHERRY JD | CONGENITAL CUTANEOUS CANDIDIASIS. | 1964 | Pediatrics | pmid:14129091 |
| Klein KC and Blackwood RA | Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. | 2006 | Pediatrics | pmid:16816005 |
| Davis TC | Chronic vulvovaginitis in children due to Shigella flexneri. | 1975 | Pediatrics | pmid:1098002 |
| Faix RG et al. | Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. | 1989 | Pediatrics | pmid:2909957 |
| Thodis E et al. | Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. | 1998 Nov-Dec | Perit Dial Int | pmid:9932656 |
| Williams PF et al. | No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. | 2000 May-Jun | Perit Dial Int | pmid:10898060 |
| Lye WC | Nystatin prophylaxis for fungal peritonitis: to be or not to be? | 2007 Sep-Oct | Perit Dial Int | pmid:17704437 |
| Wong PN et al. | Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. | 2007 Sep-Oct | Perit Dial Int | pmid:17704443 |
| Lo WK and Cheng IK | Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD? | 1999 Mar-Apr | Perit Dial Int | pmid:10357198 |